Literature DB >> 23123058

Aortic root replacement for ascending aortic disease: a 10 year review.

B Dunne1, T Marr2, D Andrews2, R Larbalestier2, M Edwards2, C Merry2.   

Abstract

BACKGROUND: Bentall's procedure and its modifications have been used for over 40 years for the treatment of ascending aortic disease. This study reviewed 10 years of experience with Aortic Root Replacement (ARR) in a major cardiac surgical centre.
METHODS: Eighty-nine patients underwent ARR between 1999 and 2009. The records were scrutinised by retrospective chart review.
RESULTS: The mean age was 54 years. Seventy-nine percent of patients were male and 21% female. The indications for the procedure were Aortic Root Aneurysm (ARA) (65%), type A dissection (28%), infective endocarditis (4.4%) and prosthetic valve regurgitation (2.2%). Fifty-seven percent of these were performed electively and 43% as an emergency. A bicuspid aortic valve was present in 37%. Arch surgery was required in 15.7%, bypass grafting in 12.3% and mitral valve surgery in 5.6%. The descending aorta was involved in 16.8%. Operative mortality was 3.3% and in-hospital mortality 12.3%. Mean follow-up was 67.05 months (range 2-143). No patients required re-operation.
CONCLUSIONS: The factors associated with increased in-hospital mortality were pre-operative haemodynamic instability, concommitant coronary artery disease and acute renal failure. The presence of a bicuspid valve may be associated with lower rates of complications, but no difference in mortality. Crown
Copyright © 2012. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23123058     DOI: 10.1016/j.hlc.2012.08.050

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  1 in total

1.  The David Operation Offers Shorter Hemostasis Time Than the Bentall in Case of Acute Aortic Dissection Type A.

Authors:  Ryohei Ushioda; Tomonori Shirasaka; Taro Kanamori; Atsuko Fujii; Makoto Shirakawa; Taro Takeuchi; Hiroyuki Kamiya
Journal:  Cureus       Date:  2022-01-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.